Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cancer
Fierce Biotech
Abbott inks $23B deal for Exact Sciences in cancer testing buy
Abbott has signed up to buy Exact Sciences in the largest diagnostics deal to date, acquiring the maker of the Cologuard at-home screening test.
Conor Hale
Nov 20, 2025 10:30am
CancerIQ's latest tools support patients with higher cancer risk
Aug 27, 2025 11:00am
UnitedHealth rolling out new early cancer detection benefit
Jul 21, 2025 4:08pm
Payer Roundup—How premiums could increase from tariffs
Jul 1, 2025 4:15pm
Supreme Court braces for ACA coverage suit oral arguments
Apr 17, 2025 2:35pm
MedStar taps Reimagine Care for virtual cancer support pilot
Apr 15, 2025 9:00am
